comparemela.com
Home
Live Updates
Mirum's LIVMARLI® Now Authorized in Canada for Cholesta
Mirum's LIVMARLI® Now Authorized in Canada for Cholesta
Mirum's LIVMARLI® Now Authorized in Canada for Cholestatic Pruritus in Patients with Alagille Syndrome | Region
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jul 25, 2023--
Related Keywords
Canada ,
United States ,
California ,
Toronto ,
Ontario ,
Andrew Mckibben ,
Chris Peetz ,
Binita Kamath ,
Roberta Smith ,
Erin Murphy ,
Nasdaq ,
Linkedin ,
European Union ,
Mirum Pharmaceuticals ,
Health Canada ,
Exchange Commission ,
Alagille Syndrome Alliance ,
Facebook ,
Instagram ,
European Commission ,
Mirum Pharmaceuticals Inc ,
Drug Administration ,
Business Wire ,
Sick Children ,
Alagille Syndrome ,
Breakthrough Therapy ,
Fat Soluble Vitamin ,
Private Securities Litigation Reform Act ,
Media Contact ,
Region ,